Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Increased DSG2 plasmatic levels identified by transcriptomic-based secretome analysis is a potential prognostic biomarker in laryngeal carcinoma.

Cury SS, Lapa RML, de Mello JBH, Marchi FA, Domingues MAC, Pinto CAL, Carvalho RF, de Carvalho GB, Kowalski LP, Rogatto SR.

Oral Oncol. 2020 Feb 19;103:104592. doi: 10.1016/j.oraloncology.2020.104592. [Epub ahead of print]

PMID:
32087405
2.

Aquaporin 1, 3, and 5 Patterns in Salivary Gland Mucoepidermoid Carcinoma: Expression in Surgical Specimens and an In Vitro Pilot Study.

Stamboni MB, Gomes ÁNM, Souza MM, Oliveira KK, Arruda CFJ, de Paula F, Bettim BB, Marques MM, Kowalski LP, Pinto CAL, Arana-Chavez VE, Lourenço SV, Coutinho-Camillo CM.

Int J Mol Sci. 2020 Feb 14;21(4). pii: E1287. doi: 10.3390/ijms21041287.

3.

Proliferating trichilemmal cyst with clinical, radiological, macroscopic, and microscopic correlation.

Valerio E, Parro FHS, Macedo MP, Pinto CAL.

An Bras Dermatol. 2019 Oct 17;94(4):452-454. doi: 10.1590/abd1806-4841.20198199. eCollection 2019.

4.

Bronchial carcinoid tumors: second primary neoplasms and outcomes of surgical treatment.

Gross JL, Vega MAT, Frenhi GS, Torres SM, Campos AHJFM, Pinto CAL, Costa FD, Haddad FJ.

J Bras Pneumol. 2019 Sep 16;45(5):e20180140. doi: 10.1590/1806-3713/e20180140. English, Portuguese.

5.

Breast sarcoidosis as the first manifestation of the disease.

Endlich JL, Souza JA, Osório CABT, Pinto CAL, Faria EP, Bitencourt AGV.

Breast J. 2020 Mar;26(3):543-544. doi: 10.1111/tbj.13560. Epub 2019 Sep 8. No abstract available.

PMID:
31495027
6.

DNA Methylation-Based Method to Differentiate Malignant from Benign Thyroid Lesions.

Barros-Filho MC, Dos Reis MB, Beltrami CM, de Mello JBH, Marchi FA, Kuasne H, Drigo SA, de Andrade VP, Saieg MA, Pinto CAL, Kowalski LP, Rogatto SR.

Thyroid. 2019 Sep;29(9):1244-1254. doi: 10.1089/thy.2018.0458. Epub 2019 Aug 16.

PMID:
31328658
7.

PFKFB2 Promoter Hypomethylation as Recurrence Predictive Marker in Well-Differentiated Thyroid Carcinomas.

Camargo Barros-Filho M, Barreto Menezes de Lima L, Bisarro Dos Reis M, Bette Homem de Mello J, Moraes Beltrami C, Lopes Pinto CA, Kowalski LP, Rogatto SR.

Int J Mol Sci. 2019 Mar 16;20(6). pii: E1334. doi: 10.3390/ijms20061334.

8.

Ameloblastoma with distinctive granular cell pattern: an 8 case study.

Cadavid AMH, Teshima THN, Pinto CAL, Camillo CMC, Lourenço SV.

Autops Case Rep. 2018 Oct 9;8(4):e2018052. doi: 10.4322/acr.2018.052. eCollection 2018 Oct-Dec.

9.

Validation of a Nomogram for Non-sentinel Node Positivity in Melanoma Patients, and Its Clinical Implications: A Brazilian-Dutch Study.

Bertolli E, Franke V, Calsavara VF, de Macedo MP, Pinto CAL, van Houdt WJ, Wouters MWJM, Duprat Neto JP, van Akkooi ACJ.

Ann Surg Oncol. 2019 Feb;26(2):395-405. doi: 10.1245/s10434-018-7038-9. Epub 2018 Nov 19.

PMID:
30456681
10.

Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma.

Ortiz IMDP, Barros-Filho MC, Dos Reis MB, Beltrami CM, Marchi FA, Kuasne H, do Canto LM, de Mello JBH, Abildgaard C, Pinto CAL, Kowalski LP, Rogatto SR.

Clin Epigenetics. 2018 Nov 20;10(1):144. doi: 10.1186/s13148-018-0579-8.

11.

A nomogram to identify high-risk melanoma patients with a negative sentinel lymph node biopsy.

Bertolli E, de Macedo MP, Calsavara VF, Pinto CAL, Duprat Neto JP.

J Am Acad Dermatol. 2019 Mar;80(3):722-726. doi: 10.1016/j.jaad.2018.10.060. Epub 2018 Nov 2.

PMID:
30395920
12.

Use of an anionic collagen matrix made from bovine intestinal serosa for in vivo repair of cranial defects.

Pettian MS, Plepis AMG, Martins VDCA, Dos Santos GR, Pinto CAL, Galdeano EA, Calegari ARA, de Moraes CA, Cunha MRD.

PLoS One. 2018 Jul 12;13(7):e0197806. doi: 10.1371/journal.pone.0197806. eCollection 2018.

13.

Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience.

Gibbons IL, Sonagli M, Bertolli E, Macedo MP, Pinto CAL, Duprat Neto JP.

An Bras Dermatol. 2018 Mar;93(2):299-301. doi: 10.1590/abd1806-4841.20187162.

14.

Panniculitis associated with amyopathic dermatomyositis.

Azevedo PO, Castellen NR, Salai AF, Barbosa FS, Alves CAXM, Pinto CAL.

An Bras Dermatol. 2018 Jan-Feb;93(1):119-121. doi: 10.1590/abd1806-4841.20186597.

15.

EGFR is not amplified in ameloblastoma.

Costa V, Fregnani ER, Fonseca FP, Abreu Alves F, Pinto CAL, Kaminagakura E.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 May;125(5):454-458. doi: 10.1016/j.oooo.2018.02.014. Epub 2018 Mar 6.

PMID:
29602688
16.

Prognostic implications of phosphatidylinositol 3-kinase/AKT signaling pathway activation in gastric carcinomas.

Chiappini PBO, de Medeiros IUD, Lima LGC, Fregnani JH, Nonogaki S, da Costa WL Jr, Coimbra FJF, Silva MJBE, de Mello CAL, Pinto CAL, Begnami MD.

Arch Med Sci. 2017 Oct;13(6):1262-1268. doi: 10.5114/aoms.2016.60394. Epub 2016 Jun 7.

17.

Expression of cancer/testis antigens MAGE-A, MAGE-C1, GAGE and CTAG1B in benign and malignant thyroid diseases.

Melo DH, Mamede RCM, Neder L, Silva WA Jr, Barros-Filho MC, Kowalski LP, Pinto CAL, Zago MA, Figueiredo DLA, Jungbluth AA.

Oncol Lett. 2017 Dec;14(6):6485-6496. doi: 10.3892/ol.2017.7072. Epub 2017 Sep 26.

18.

Role of GAD peptides p217 and p290 in the repair of INS receptor in salivary tissues of type 1 diabetic mice.

da Silva RE, Cervigne NK, Pinto CAL, da Cunha MR, Rojas F, Peroni LA, Augusto TM, Marchi E, Khan BA, Caldeira EJ.

Pak J Pharm Sci. 2017 Sep;30(5):1545-1550.

PMID:
29084671
19.

Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors.

Bisarro Dos Reis M, Barros-Filho MC, Marchi FA, Beltrami CM, Kuasne H, Pinto CAL, Ambatipudi S, Herceg Z, Kowalski LP, Rogatto SR.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099. doi: 10.1210/jc.2017-00881.

20.

Pemphigus foliaceus as a differential diagnosis in vesicobullous lesions.

Fonseca LAF, Alves CAXM, Aprahamian I, Pinto CAL.

Einstein (Sao Paulo). 2017 Apr-Jun;15(2):220-222. doi: 10.1590/S1679-45082017RC3828. English, Portuguese.

Supplemental Content

Loading ...
Support Center